Changes in the guideline reflect the increased data on direct-acting oral anticoagulants.
Note to readers: The language in the third and fourth bullet points has been updated since the original online publication of the Guideline Watch.
Sponsoring Organizations: American College of Cardiology, American Heart Association, and Heart Rhythm Society (AHA/ACC/HRS)Target Audience: General cardiologists and cardiac electrophysiologists
Background and Objective
The guideline task force has updated key aspects of the 2014 ACC/AHA/HRS atrial fibrillation (AF) guideline, especially with regards to new data on direct anticoagulants.
Key Points
Female sex, if the only risk factor, does not confer a CHA2DS2-VASc score of 1. Female sex adds to the score only when another risk factor is present. Oral anticoagulants are recommended for patients with …
Reviewing Author
DisclosuresEditorial BoardsCirculation; UpToDate
DisclosuresEditorial BoardsCirculation; UpToDate